Annual Statements Open main menu

Wright Investors Service Holdings, Inc. - Quarter Report: 2008 March (Form 10-Q)

m5148210q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the quarterly period ended March 31, 2008
   
 
or
   
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from _____ to _____
 
Commission File Number: 000-50587

NATIONAL PATENT DEVELOPMENT CORPORATION
(Exact Name of Registrant as Specified in its Charter)


Delaware
 
13-4005439
(State or other jurisdiction of
incorporation or organization
 
(I.R.S. Employer
Identification No.)

10 East 40th Street, Suite 3110, New York, NY
10016
(Address of principal executive offices)
(Zip code)

(646) 742-1600
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer
  o
Accelerated filer
  o
Non-accelerated filer
(Do not check if a smaller reporting company)
  o
Smaller reporting company
  x

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o      No x
 
As of May 10, 2008, there were 16,148,621 shares of the registrant’s common stock, $0.01 par value, outstanding.
 



 
 
 

NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS
 

 
Part I.  Financial Information 
  Page No.
 
     
   
 
1
     
   
 
2
     
   
 
3
     
   
 
4
     
   
 
5
     
 
6
     
 
 
17
     
24
     
24
 
 
Part II. Other Information 
 
 
24
     
25
   
26



PART I. FINANCIAL INFORMATION

Item 1.                      Financial Statements

NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
(in thousands, except per share data)

   
Three Months Ended
 
   
March 31,
 
   
2008
   
2007
 
             
Sales
  $ 33,808     $ 31,931  
Cost of sales
    (28,023 )     (26,841 )
Gross margin
    5,785       5,090  
                 
Selling, general and administrative expenses
    (5,825 )     (4,702 )
Charge related to resignation of Chairman of the Board of Five Star
    (1,096 )        
                 
Operating profit (loss)
    (1,136 )     388  
                 
Interest expense
    (340 )     (326 )
Investment and other income
    100       66  
                 
Income (loss) before income taxes and minority interest
    (1,376 )     128  
                 
Income tax expense
    (14 )     (360 )
                 
Loss before minority interest
    (1,390 )     (232 )
                 
Minority interest
    13       (195 )
                 
Net loss
  $ (1,377 )   $ (427 )
                 
Net loss per share
               
Basic and diluted
  $ (0.08 )   $ (0.02 )

See accompanying notes to consolidated condensed financial statements.

 
NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
(in thousands)

   
Three Months Ended
March 31,
 
   
2008
   
2007
 
             
Net loss
  $ (1,377 )   $ (427 )
                 
Other comprehensive (loss) income, before tax:
               
Net unrealized gain (loss) on available-for-sale-securities
    (66 )     178  
Net unrealized (loss) gain on interest rate swap, net of minority interest
    (70 )     (48 )
                 
Comprehensive loss before tax
    (1,513 )     (297 )
                 
Income tax benefit (expense) related to items of other comprehensive income
    32       15  
                 
Comprehensive loss
  $ (1,481 )   $ (282 )

See accompanying notes to consolidated condensed financial statements.

 
NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)

   
March 31,
2008
   
December 31,
2007
 
   
(unaudited)
       
Assets
           
Current assets
           
Cash and cash equivalents
  $ 12,366     $ 15,698  
Accounts receivable, less allowance
               
for doubtful accounts of $216 and $412
    20,750       12,755  
Inventories
    33,806       27,720  
Prepaid expenses and other current assets
    805       1,326  
Deferred tax asset
    470       470  
Total current assets
    68,197       57,969  
                 
Marketable securities available for sale
    44       109  
Property, plant and equipment, net
    3,522       3,534  
Goodwill
    96          
Deferred tax asset
    190          
Other assets
    2,918       3,293  
Total assets
  $ 74,967     $ 64,905  
                 
Liabilities and stockholders’ equity
               
Current liabilities
               
Current maturities of long-term debt
  $ 257     $ 257  
Short term borrowings
    28,101       19,928  
Accounts payable and accrued expenses
    18,914       13,530  
Total current liabilities
    47,272       33,715  
                 
Long-term debt less current maturities
    1,377       1,441  
Deferred tax liability
    279       279  
                 
Minority interest
    1,677       2,902  
Common stock subject to exchange rights
            493  
                 
Stockholders’ equity
               
Common stock
    180       180  
Additional paid-in capital
    27,322       26,825  
Retained earnings
    1,168       2,545  
Treasury stock, at cost
    (4,187 )     (3,458 )
Accumulated other comprehensive loss
    (121 )     (17 )
Total stockholders’ equity
    24,362       26,075  
Total liabilities and stockholders’ equity
  $ 74,967     $ 64,905  

See accompanying notes to consolidated condensed financial statements.

 
NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)

   
Three Months Ended
 
   
March 31,
 
   
2008
   
2007
 
Cash flows from operations:
           
Net loss
  $ (1,377 )   $ (427 )
Adjustments to reconcile net loss to
               
  net cash used in operating activities:
               
 Depreciation and amortization
    179       190  
 Minority interest
    (13 )     195  
 Gain on issuance of stock by a subsidiary
            (1 )
 Expenses paid in common stock
    15       13  
 Deferred income taxes
    (190 )     (51 )
 Stock based compensation
    985       62  
 Changes in other operating items:
               
 Accounts receivable
    (7,995 )     (7,576 )
 Inventory
    (6,086 )     (3,031 )
 Prepaid expenses an other assets
    316       (598 )
 Accounts payable and accrued expenses
    5,384       9,907  
Net cash used in operations
    (8,782 )     (1,317 )
                 
Cash flows from investing activities:
               
Additions to property, plant and equipment, net
    (167 )     (845 )
Acquisition of additional interest in Five Star
    (1,523 )     (106 )
Repayment of receivable from GP Strategies
            185  
Net cash used in investing activities
    (1,690 )     (766 )
                 
Cash flows from financing activities:
               
Proceeds from sale of common stock
            480  
Purchases of treasury stock
    (729 )     (220 )
Settlement of option
    (240 )        
Proceeds from short-term borrowings
    8,173       1,184  
Proceeds from long-term debt
            273  
Repayment of long-term debt
    (64 )     (25 )
Net cash provided by financing activities
    7,140       1,692  
                 
Net increase (decrease) in cash and cash equivalents
    (3,332 )     (391 )
Cash and cash equivalents at beginning of period
    15,698       4,485  
Cash and cash equivalents at end of period
  $ 12,366     $ 4,094  

See accompanying notes to the consolidated condensed financial statements.

 
NATIONAL PATENT DEVELOPMENT CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
THREE MONTHS ENDED MARCH 31, 2008
(Unaudited)
(in thousands, except shares and per share data)
 
 
   
Common
Stock
$(0.01 par
value)
   
 
Additional
paid-in
capital
   
 
 
Retained
earnings
   
 
Treasury
stock, at cost
   
Accumulated
other comprehensive income (loss)
   
 
Total
stockholders’
equity
 
 
 
Balance at December 31, 2007
  $ 180     $ 26,825     $ 2,545     $ (3,458 )   $ (17 )   $  26,075  
Net unrealized loss on available
for sale securities
                                    (66 )     (66 )
Net unrealized loss on interest  rate swap, net of tax and minority interest
                                    (38 )     (38 )
Net loss
                    (1,377 )                     (1,377 )
Equity based compensation expense
            229                                229  
Settlement of option to acquire shares of Five Star
            (240 )                             (240 )
Purchase of 300,000 shares of
  treasury Stock
                            (729 )             (729 )
Reclassification of common stock subject to exchange rights
            493                               493  
Issuance of 3,866 shares of common stock to MXL  Retirement and Savings Plan
              9                                 9  
Issuance of 2,557 shares of   common stock to directors
            6                               6  
 
Balance at March 31, 2008
  $ 180     $ 27,322     $ 1,168     $ (4,187 )   $ (121 )   $ 24,362  

See accompanying notes to the consolidated condensed financial statements.

 
NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(Unaudited)

1.                      Basis of presentation and description of business
 
Basis of presentation
 
The accompanying Consolidated Condensed Balance Sheet as of March 31, 2008 and the Consolidated Condensed Statements of Operations and Cash Flows for the three months ended March 31, 2008 and 2007 have not been audited, but have been prepared in conformity with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  The Consolidated Condensed Balance Sheet as of December 31, 2007 has been derived from audited financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2007 as presented in our Annual Report on Form 10-K. In the opinion of management, this interim information includes all material adjustments, which except for the compensation charge referred to in Note 13 to the Consolidated Condensed Financial Statements, are of a normal and recurring nature, necessary for a fair presentation. The results for the 2008 interim period are not necessarily indicative of results to be expected for the entire year.
 
Description of business. National Patent Development Corporation (the “Company” or “National Patent Development”), through its wholly owned subsidiary, MXL Industries, Inc. (“MXL”), manufactures polycarbonate parts requiring strict adherence to optical quality specifications, and in the application of abrasion and fog resistant coating to these parts. Products include shields and face masks and non-optical plastic products. The Company’s 75% owned subsidiary, Five Star Products, Inc. (“Five Star”), is engaged in the wholesale distribution of home decorating, hardware and finishing products. Five Star serves independent retail dealers in 12 states in the Northeast. Products distributed include paint sundry items, interior and exterior stains, brushes, rollers, caulking compounds and hardware products.
 
Recent Accounting Pronouncements
 
In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”, which defines fair value, establishes a framework for measurement of fair value and expands disclosures about fair value measurements. SFAS No. 157 clarifies that fair value should be based on assumptions that market participants will use when pricing an asset or liability and establishes a fair value hierarchy of three levels that  prioritize the information used to develop those assumptions. The provisions of SFAS No. 157 became effective for the Company beginning January 1, 2008. Generally, the provisions of this statement are to be applied prospectively. The Company adopted SFAS No. 157 in the first quarter of 2008. The adoption of SFAS No. 157 did not have a material effect on the Company’s consolidated financial statements.
 
In February, 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities”.  This statement provides companies with an option to report selected financial assets and liabilities at fair value. Although, this statement became effective for the Company beginning January 1, 2008, the Company did not elect to value any financial assets and liabilities at fair value.
 
In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements — an amendment of Accounting Research Bulletin (“ARB”) No. 51” (“SFAS 160”).  SFAS 160 requires that ownership interests in subsidiaries held by parties other than the parent, and the amount of consolidated net income, be clearly identified, labeled, and presented in the consolidated financial statements within equity, but separate from the parent’s equity. It also requires once a subsidiary is deconsolidated, any retained noncontrolling equity investment in the former subsidiary be initially measured at fair value. Sufficient disclosures are required to clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners.  SFAS No. 160 is effective for fiscal years beginning after December 15, 2008, and is to be applied retrospectively for all periods presented.  Accordingly, upon the adoption of SFAS No. 160, the Company’s financial statements will be reclassified to reflect the minority interest in Five Star in accordance with this statement.

 
In December 2007, the FASB issued SFAS No. 141 (Revised 2007), “Business Combinations”. SFAS No. 141(R), replaces SFAS No. 141, “Business Combinations”, and establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree, and any goodwill acquired in a business combination. SFAS No. 141(R) also establishes disclosure requirements to enable the evaluation of the nature and financial effects of a business combination. SFAS No. 141(R) is to be applied prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008.  The impact that the adoption of SFAS No. 141(R) will have on the Company’s financial statements is not presently determinable, since it is dependant on future acquisitions, if any.
 
In March 2008, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 161 (“SFAS No. 161”), “Disclosures about Derivative Instruments and Hedging Activities - an amendment of FASB Statement No. 133”. SFAS No. 161 gives financial statement users better information about the reporting entity's hedges by providing for qualitative disclosures about the objectives and strategies for using derivatives, quantitative data about the fair value of and gains and losses on derivative contracts, and details of credit-risk-related contingent features in their hedged positions. The standard is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application encouraged, but not required. The Company does not anticipate that the adoption of SFAS No. 161 will have a material effect on the Company’s consolidated financial statements.
 
Use of estimates. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
 
Concentrations of credit risk. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash investments, and accounts receivable from customers. The Company places its cash investments with high quality financial institutions and limits the amount of credit exposure to any one institution.
 
2.                      Per share data
 
Basic and diluted net loss per share for the three months ended March 31, 2008 and 2007 is based upon the weighted average number of the Company’s shares outstanding during the periods. Outstanding warrants to acquire 1,423,887 shares of common stock issued in December 2004 and options to acquire 3,350,000 shares of common stock issued by the Company in 2007 were not included in the March 31, 2008 and 2007 diluted computation since their effect will be anti-dilutive.  In addition, the effect on the fully diluted computation of outstanding options of Five Star was anti-dilutive and accordingly did not effect the March 31, 2008 and 2007 diluted computation.
 
Loss per share for the three months ended March 31, 2008 and 2007 are as follows (in thousands, except per share amounts):
 
 
Three months ended
 
 
March 31,
 
 
2008
 
2007
 
Basic and Diluted EPS
           
Net loss
  $ (1,377 )   $ (427 )
Weighted average shares
               
  outstanding, basic and diluted
    16,461       17,758  
Basic and diluted loss per share
  $ (0.08 )   $ (0.02 )

3.                      Treasury Stock
 
On December 15, 2006, the Company’s Board of Directors authorized the Company to repurchase up to 2,000,000 shares, or approximately 11%, of its then outstanding shares of common stock from time to time either in open market or privately negotiated transactions. At March 31, 2008, the Company had repurchased 1,628,462 shares of its common stock for $3,706,000 under the repurchase plan (excluding the purchase from Mr. Flegel in March 2008 which was not under such plan; see Note 13 to the Consolidated Condensed Financial Statements).
 

4.                      Acquisition of Right-Way Dealer Warehouse
 
On April 5, 2007, Five Star acquired substantially all the assets of Right-Way Dealer Warehouse, Inc. (“Right-Way”) for approximately $3,200,000 in cash and the assumption of liabilities in the approximate amount of $50,000. Transaction costs of approximately $200,000 were incurred by Five Star in connection with this transaction. The assets consisted primarily of approximately $1,186,000 of accounts receivable at fair value and approximately $2,213,000 of inventory at fair value. The acquisition included all of Right-Way’s Brooklyn Cash & Carry business and operations.  Five Star acquired the assets of Right-Way in order to increase its presence and market share in its current geographic area.
 
The results of operations of Right-Way are included in the consolidated financial statements from the date of acquisition.  The following unaudited pro forma consolidated amounts give effect to the acquisition of Right-Way as if it had occurred on January 1, 2007. Right-Way had filed for reorganization under Chapter 11 of the United States Bankruptcy Code prior to the acquisition by Five Star.  The pro forma results of operations have been prepared for comparative purposes only and are not necessarily indicative of the operating results that would have been achieved had the acquisition been consummated as of the above date, nor are they necessarily indicative of future operating results.
 

 
(in thousands, except per share data)
 
Three months ended
March 31,
2007
 
 
Sales
  $ 36,265  
Net loss
    (763 )
Earnings (loss) per share
       
   Basic and fully diluted
  $ (0.04 )

5.                       Incentive stock plans and stock based compensation
 
The Company and Five Star have stock-based compensation plans for employees and non-employee members of their respective Boards of Directors. The plans provide for discretionary grants of stock options, restricted stock shares, and other stock-based awards. The Company’s plans are administered by the Compensation Committee of the Board of Directors, consisting solely of non-employee directors, and the Five Star plans are administered by Five Star’s entire Board of Directors.
 
Company Stock Option Plan
 
On November 3, 2003, GP Strategies, which at the time was the Company’s parent, adopted an Incentive Stock Plan (the “2003 Plan”) under which 1,750,000 shares of the Company’s common stock are available for grant to employees, directors and outside service providers.  The 2003 Plan permits awards of incentive stock options, nonqualified stock options, restricted stock, stock units, performance shares, performance units and other incentives payable in cash or in shares of the Company common stock.  The term of any option granted under the 2003 Plan will not exceed ten years from the date of grant and, in the case of incentive stock options granted to a 10% or greater holder in the total voting stock of the Company, three years from the date of grant.  The exercise price of any option will not be less than the fair market value of the common stock on the date of grant or, in the case of incentive stock options granted to a 10% or greater holder in the total voting stock, 110% of such fair market value.
 
On March 1, 2007, the Company’s Board of Directors approved and adopted an amendment, subject to stockholder approval (the “Amendment”), to the 2003 Plan increasing the aggregate number of shares of Company common stock issuable under the 2003 Plan from 1,750,000 shares to 3,500,000 shares (subject to adjustment as provided in the 2003 Plan), and increasing the per person annual limitation in the 2003 Plan from 250,000 shares to 2,500,000 shares.  The Amendment was approved in December 2007 at the Company’s 2007 Annual Stockholders Meeting.

 
In March 2007, the Company granted an aggregate of 3,200,000 nonqualified stock options to officers and directors under the 2003 Plan, of which 632,830 were granted under the terms of the 2003 Plan as presently approved by the Company’s stockholders and the remainder were granted subject to stockholder approval of the amendment referred to above.  The Company determined the estimated aggregate fair value of the 632,830 options which were not subject to stockholder approval on the date of grant and  upon stockholder approval , which under SFAS 123R is considered the date of grant, determined the estimated aggregate fair value of the remaining 2,567,170 options. On July 30, 2007, the Company granted an aggregate of 150,000 non-qualified stock options under the 2003 Plan.
 
On July 30, 2007, the Board of Directors adopted the National Patent Development Corporation 2007 Incentive Stock Plan (the “2007 NPDC Plan”), subject to stockholder approval.  The 2007 NPDC Plan was approved by the Company’s stockholders in December 2007 at the Company’s 2007 Annual Stockholders Meeting.  As of March 31, 2008, no awards have been granted under the 2007 NPDC Plan.  The number of shares of common stock reserved and available for awards under the 2007 NPDC Stock Plan (subject to certain adjustments as provided therein) is 7,500,000.
 
A summary of the Company’s stock option activity as of March 31, 2008, and changes during the quarter then ended, is presented below:
 
 
Stock
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Contractual
Term
 
Aggregate
Intrinsic
Value
               
Options outstanding at January 1, 2008
 
3,350,000
 
$
2.49
   
9.2
 
$
768,000*
Options outstanding  at March 31, 2008
 
3,350,000
   
2.49
   
9.0
 
$
0 *
Options exercisable at March 31, 2008
 
1,067,000
 
$
2.45
   
9.0
 
$
0 *
       
 
*
The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
 
The weighted average grant-date fair value of the options granted during 2007 was $0.82 per share.
 
As of March 31, 2008, there was $1,749,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the vesting periods of the options, which on a weighted-average basis is approximately 1.9 years.
 
Five Star Stock Option Plans
 
Five Star has adopted the Five Star Products, Inc. 1994 Stock Option Plan, effective August 5, 1994 (the “1994 Plan”). The 1994 Plan, which was amended on January 1, 2002, provides for 4,000,000 shares of common stock to be reserved for issuance, subject to adjustment in the event of stock splits, stock dividends, recapitalizations, reclassifications or other capital adjustments. Unless designated as “incentive stock options” intended to qualify under Section 422 of the Internal Revenue Code, options granted under the 1994 Plan are intended to be nonqualified options. Although certain outstanding options have been granted under the 1994 Plan, options may no longer be granted under the plan.
 
On March 1, 2007, the Board of Directors of Five Star adopted the Five Star Products, Inc. 2007 Incentive Stock Plan (the “2007 FS Plan”), which was approved by the stockholders of Five Star in December 2007. Under the 2007 FS Plan, Five Star may grant awards of non-qualified stock options, incentive stock options, restricted stock, stock units, performance shares, performance units, and other incentives payable in cash or in shares of Five Star common stock to officers, employees or members of the Board of Directors of Five Star and its subsidiaries. Five Star is authorized to grant an aggregate of 2,500,000 shares of Five Star common stock under the 2007 FS Plan.  Five Star may issue new shares or use shares held in treasury to deliver shares for equity grants or upon exercise of non-qualified stock options.

 
On March 2, April 5 and July 17, 2007, Five Star granted options under the 2007 Plan to purchase an aggregate of 250,000, 200,000 and 125,000 shares of Five Star common stock with exercise prices of $0.38, $0.75 and $0.78 per share, respectively, to certain executives of Five Star. The options vest if Five Star meets certain EBITDA targets for each of the three consecutive years beginning with the fiscal year ended December 31, 2007 or in aggregate for the three year period ending December 31, 2010 and are contingent upon continued employment with Five Star.  Additionally, on March 2, 2007 Five Star modified EBITDA target for 400,000 options granted  to an executive officer of Five Star in October 2006, for which no compensation expenses was recognized in the fiscal year ended December 31, 2006 as achievement of performance criteria was determined to be less than probable. Five Star estimated the aggregate fair value of these options to be $185,000, $97,000 and $62,000, respectively, based on the Black-Scholes valuation model. It was determined in March 2008 that the 2007 performance criteria was met for the year ended December 31, 2007 and therefore aggregate compensation expense of $24,000 was recognized with respect to these performance based  options for the three months ended March 31, 2008. Five Star and the Company estimates that achievement of 2008 performance target is less then probable and therefore no compensation expenses were recognized with respect to the portion of the above grants which will vest based on achievement of the 2008 target.
 
As of March 31, 2008, there was $235,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements of Five Star. This cost is expected to be recognized over the vesting periods of the options, which on a weighted-average basis is approximately 1.9 years.
 
Activity relating to stock options granted by Five Star:
 
 
 
Number of
Shares
 
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Terms (Years)
 
 
Aggregate
Intrinsic
Value
 
Options outstanding at January 1, 2008
 
975,000
 
$
0.51
   
9.2
 
$
201,500
(*)
Options outstanding at March 31, 2008
 
975,000
  $
0.51
   
9.0
 
$
19,500
 
Options vested and expected to vest
 
325,000
 
$
0.51
   
9.0
 
$
6,500
 
Options exercisable at March 31, 2008
 
325,000
 
$
0.51
   
9.0
 
$
6,500
 
 
*
The intrinsic value of stock options is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
 
The total intrinsic value of options exercised during the year ended December 31, 2007 was $124,000.
 

 
On March 2, 2007, Five Star granted to its President and Chief Executive Officer, 1,000,000 shares of Five Star restricted stock, valued at $0.38 per share (representing an aggregate value of $380,000), vesting upon the achievement by Five Star of certain EBITDA targets for the fiscal year ended December 31, 2007 and the following two successive years, contingent upon his continued employment with the Company and Five Star.  In March 2008, Five Star determined that achievement of the 2007 performance criterion was met; therefore compensation expense of $21,000 was recognized by Five Star for the three months ended March 31, 2008 and restrictions on 333,000 shares of Five Star restricted stock lapsed. At March 31, 2008 $253,000 remains to be charged over the lesser of the remaining 23 months or the term of employment, provided certain adjusted EBITDA targets are met.  However at March 31, 2008, Five Star determined that the achievement of 2008 performance target is less than probable and therefore no compensation expense was recognized with respect to the portion of the grant that vests based on the achievement of the 2008 performance target.
 

6.                      Long-term debt
 
Long-term debt
 
Long-term debt is comprised of the following (in thousands):
 
   
March 31,
2008
   
December 31,
2007
 
MXL Pennsylvania Mortgage (a)
  $ 980     $ 1,105  
MXL Term loan (b)
    654       693  
Capital lease obligations
            1  
      1,634       1,698  
Less current maturities
    (257 )     (257 )
    $ 1,377     $ 1,441  

 
(a)
The loan, which is collateralized by real estate and fixtures, requires monthly repayments of $8,333 plus interest at 2.5% above the one month LIBOR rate and matures on March 8, 2011, when the remaining amount outstanding of approximately $680,000 is due in full. The loan is guaranteed by GP Strategies Corporation (“GPS”).
 
 
(b)
On November 27, 2006, MXL entered into a 5 year $785,000 Term Loan for the financing of machinery and equipment at 2.5% above the one month LIBOR rate, or 0.25% above the bank’s prime lending rate, as applicable. In May 2007, the loan balance was converted to a five year Term Loan, with monthly payments of principal and accrued interest through May 2012. The Term Loan is guaranteed by the Company and collateralized by MXL’s Lancaster, PA property.
 
7.                      Short-term borrowings
 
Five Star short-term borrowings
 
In 2003, Five Star obtained a Loan and Security Agreement (the “Loan Agreement”) with Bank of America Business Capital (formerly Fleet Capital Corporation) (the “Lender”). The Loan Agreement has a five-year term, with a maturity date of June 30, 2008. The Loan Agreement, as amended in August 1, 2005, and again in March 2008, provides for a $35,000,000 revolving credit facility, which allows Five Star to borrow based upon a formula up to 65% of eligible inventory and 85% of eligible accounts receivable, as defined therein. The interest rates under the Loan Agreement consist of LIBOR plus a credit spread of 1.5% (4.57% at March 31, 2008) for borrowings not to exceed $15,000,000 and the prime rate (5.25% at March 31, 2008) for borrowings in excess of the above-mentioned LIBOR-based borrowings. The credit spreads can be reduced in the event that Five Star achieves and maintains certain performance benchmarks. At March 31, 2008 and December 31, 2007, approximately $27,476,000 and $19,303,000 was outstanding under the Loan Agreement and approximately $7,390,000 and $5,579,000 was available to be borrowed, respectively. Substantially all of Five Star’s assets are pledged as collateral for these borrowings. Under the Loan Agreement Five Star is subject to covenants requiring minimum net worth, limitations on losses, if any, and minimum or maximum values for certain financial ratios. The Lender amended the covenants related to the Loan Agreement in March 2008 to exclude non-cash charges related to any equity instruments (common stock, options and warrants) issued to any employee, director, or consultant from the covenant calculations (see Note 13). As of March 31, 2008 Five Star was in compliance with all required covenants.
 
In connection with the Loan Agreement, Five Star also entered into a derivative transaction with the Lender. The derivative transaction is an interest rate swap and has been designated as a cash flow hedge. Effective July 1, 2004 through June 30, 2008, Five Star will pay a fixed interest rate of 3.38% to the Lender on notional principal of $12,000,000. In return, the Lender will pay to Five Star a floating rate, namely, LIBOR, on the same notional principal amount. The credit spread under the new Loan Agreement is not included in, and will be paid in addition to this fixed interest rate of 3.38%. The fair value of the interest rate swap amounted to $(29,000) and $69,000 at March 31, 2008 and December 31, 2007, respectively, and is included in other assets in the accompanying balance sheets.

 
On June 17, 2004, Five Star also entered into a derivative interest rate collar transaction during the period from July 1, 2004 through June 30, 2008 on notional principal of $12,000,000. The transaction consists of an interest rate floor of 2.25%, whereby if LIBOR is below 2.25%, the Lender will pay to Five Star the difference between LIBOR and 2.25%, on the same notional principal amount. The transaction also consists of an interest rate cap of 5.75%, whereby if LIBOR is above 5.75%, Five Star will pay to the Lender the difference between LIBOR and 5.75%, on the same notional principal amount.
 
MXL short-term borrowings
 
On March 1, 2005, MXL obtained a Line of Credit Loan (the “MXL Line”) from M&T Bank with a one year term, maturing on March 1, 2006, which has been extended to June 30, 2008 on the same terms. The MXL Line provides for a $1,000,000 revolving credit facility, which is secured by MXL’s eligible accounts receivable, inventory and a secondary claim on the Lancaster, PA property. On November 27, 2006, the MXL Line was amended to a $900,000 line of credit. The interest rates under the MXL Line consist of LIBOR plus a credit spread of 2.5% or the prime rate. The MXL Line is subject to an unused commitment fee of 0.125% of the average daily unused balance of the line payable quarterly. The Company has guaranteed the MXL Line up to $785,000. At March 31, 2008 and December 31, 2007, $625,000 was outstanding under the MXL Line and $275,000 was available to be borrowed at March 31, 2008. The MXL Line contains certain financial covenants which are calculated on an annual basis at December 31. As of December 31, 2007, MXL was in compliance with its covenants.
 
8.                      Inventories
 
Inventories are comprised of the following (in thousands):
 
   
March 31, 2008
   
December 31, 2007
 
Raw materials
  $ 444     $ 410  
Work in process
    276       141  
Finished goods
    33,086       27,169  
    $ 33,806     $ 27,720  
 
9.                      Investment in Valera Pharmaceuticals, Inc. (“Valera”)
 
Indevus Pharmaceuticals, Inc. (“Indevus”) is a biopharmaceutical company that engages in the acquisition, development, and commercialization of products to treat urological, gynecological, and men’s health conditions.
 
Effective April 18, 2007 (the “Effective Time”), all of the outstanding common stock of Valera Pharmaceuticals, Inc. (“Valera”), a Delaware corporation in which the Company had owned 2,070,670 shares of common stock at such time, was acquired by Indevus pursuant to the terms and conditions of an Agreement and Plan of Merger, dated as of December 11, 2006 (the “Merger Agreement”).  Pursuant to the Merger Agreement, the Company received 1.1337 shares of Indevus common stock for each share of Valera common stock held by the Company immediately prior to the Effective Time. As a result, the 2,070,670 shares of Valera common stock held by the Company were converted into an aggregate of 2,347,518 shares of Indevus common stock.  In April 2007, the Company recognized a pre-tax gain of $14,961,000 resulting from the exchange of shares.   In addition, for each share of Valera common stock held by the Company immediately prior to the Effective Time, the Company received one contingent stock right for each of three Valera product candidates in development - Supprelin-LA, a ureteral stent and VP003 (Octreotide implant) – convertible into $1.00, $1.00 and $1.50, respectively, worth of Indevus common stock to the extent specific milestones with respect to each product candidate are achieved. Thus, if all contingent milestones are achieved, the Company will receive $2,070,670, $2,070,670 and $3,106,005, respectively, worth of Indevus common stock on the date the milestones are met, at which date additional gain will be recognized. On May 3, 2007, Indevus announced that it had received FDA approval for Supprelin-LA.  Therefore, in May 2007, the Company received, 291,964 shares of Indevus common stock, and recognized an additional pre-tax gain of $2,070,670.   During the year ended December 31, 2007, the Company sold all 2,639,482 shares of Indevus common stock held by the Company on the open market, for total net proceeds of $17,598,000.
 
Two related parties, Bedford Oak Partners and Mr. Jerome I. Feldman, were entitled to receive 50% of any profit received from the sale on a pro-rata basis, of 458,019 shares of Indevus common stock in excess of $3.47 per share, and are entitled to participate in 50% of the profits earned on 19.51% of shares of Indevus common stock received by the Company upon conversion of the contingent stock rights, described above, if any, at such time as such shares are sold by the Company (see Note 11(a)). The Company paid $922,000 to the related parties towards their profit share, upon sale of Indevus.  For the three months ended March 31, 2007, the Company recognized a loss of $16,000.
 
 
10.                    Business segments
 
The operations of the Company currently consist of the following two business segments, by which the Company is managed.
 
The MXL Segment manufactures precision coated and molded optical plastic products. MXL is a specialist in the manufacture of polycarbonate parts requiring adherence to strict optical quality specifications, and in the application of abrasion and fog resistant coatings to those parts.
 
The Five Star Segment distributes paint sundry items, interior and exterior stains, brushes, rollers, caulking compounds and hardware products on a regional basis.
 
The following tables set forth the sales and operating income (loss) of each of the Company’s operating segments (in thousands):
 
   
Three months
ended March 31,
   
   
2008
   
2007
Sales
         
Five Star
  $ 31,469     $ 29,861  
MXL
    2,339       2,070  
    $ 33,808     $ 31,931  


 
Three months
ended March 31,
 
 
2008
 
2007
 
Segment operating income (loss)
       
Five Star
  $ (351 )   $ 1,138  
MXL
    169       (129 )
    $ (182 )   $ 1,009  



 
 
A reconciliation of the segment operating income (loss) to loss before income taxes and minority interest in the consolidated condensed statements of operations is shown below (in thousands):
 
   
Three months
 
   
ended March 31,
 
   
2008
   
2007
 
Segment operating income (loss)
  $ (182 )   $ 1,009  
Corporate and other general and administrative expenses
    (954 )     (621 )
Interest expense
    (340 )     (326 )
Investment and other income (loss)
    (139 )     66  
Income (loss) before income taxes
               
and minority interest
  $ (1,615 )   $ 128  

 
11.                    Related party transactions
 
(a)           On November 12, 2004, the Company entered into an agreement to borrow approximately $1,022,000 from Bedford Oak Partners, which is controlled by Harvey P. Eisen, Chairman, Chief Executive Officer and a director of the Company, and approximately $568,000 from Jerome I. Feldman, who was at the time Chairman and Chief Executive Officer of the Company, which was utilized to exercise an option held by the Company to purchase Series B Convertible Preferred shares of Valera.  The loans bore interest at 6% per annum, matured on October 31, 2009, and were secured by all shares of Valera owned by the Company, including the purchased shares.    On January 11, 2005, the Company prepaid the loans and all accrued interest in full. As further consideration for making these loans, Bedford Oak Partners and Mr. Feldman became entitled to a portion of the consideration received by the Company on the sale of certain Valera shares.
 
 As a result of the acquisition of Valera by Indevus (see Note 9 to the Consolidated Condensed Financial Statements) this obligation presently relates to the sale of Indevus shares by the Company. From June 2007 through and including September 12, 2007, the Company sold, in a series of open market transactions, all of the 2,639,482 shares of Indevus common stock held by the Company for an aggregate of approximately $17,598,000, net of commissions and brokerage fees.  The November 12, 2004 agreement among the Company, Bedford Oak Partners and Mr. Feldman provides for Bedford Oak Partners and Mr. Feldman to (i) receive 50% of any amount in excess of $3.47 per share which is received by the Company upon the sale of Indevus common stock and (ii) participate in 50% of the profits earned on 19.51% of shares of Indevus common stock received by the Company upon conversion of the contingent stock rights, described below, if any, at such time as such shares are sold by the Company.  The aggregate amount paid in 2007 towards the profit sharing was $922,000.
 
The Company continues to hold contingent stock rights for certain products in development by Indevus that will become convertible into shares of Indevus common stock to the extent specific milestones with respect to each product are achieved.  If the remaining milestones are achieved, the Company will receive $2,070,670 and $3,106,005, respectively, worth of shares of Indevus common stock upon conversion of such contingent stock rights. 
 
(b)           Concurrently with its spin-off from GP Strategies, the Company and GP Strategies entered into a management agreement under which certain of the Company’s executive officers who were also executive officers of GP Strategies were paid by GP Strategies subject to reimbursement by the Company. Additionally, GP Strategies provided support with respect to corporate federal and state income taxes, corporate legal services, corporate secretarial administrative support, and executive management consulting.  The agreement terminated on November 24, 2007.
 
Expenses incurred by the Company under this agreement were $201,000 for the three months ended March 31, 2007 which includes approximately 80% of the cost of the compensation and benefits required to be provided by GP Strategies to Jerome Feldman, who served as the Company’s Chief Executive Officer until May 31, 2007.
 
12.                    Contingent liabilities
 
(a)           In connection with its land investments, the Company has certain ownership interests in several dams and related reservoirs located in the State of Connecticut.  Under relevant Connecticut law, the Company is responsible for maintaining the safety of these dams.  The Company has been notified by certain landowners adjoining one of the reservoirs that the water level in the reservoir has decreased; allegedly causing harm to such landowners.  While the Company is currently investigating the cause of the decline in the water level, it does not presently know the cause of the decrease in water level or have any reasonable estimation of the cost of repairs, if any, that may be required.  Further, the Company cannot presently determine the extent of its legal liability, if any, with respect to the landowners.  The Company has not received any claims with respect to any of the other reservoirs.  The Company cannot reasonably estimate at this time the costs which may be incurred with respect to this matter and while these costs could be material to the Company’s results of operations in the period incurred, based upon the present state of its knowledge, the Company has no reason to believe that these costs will be material to its financial position.  No amounts have been provided for this matter in the accompanying financial statements.
 
(b)           The Company and its subsidiaries are from time to time involved in litigation arising out of the ordinary course of business. It is the view of management that the ultimate resolution of the only presently pending lawsuit (which is for a health related claim based on the alleged use of a product claimed to be distributed by Five Star) should not have a material adverse effect on the consolidated financial position, results of operations or cash flows of the Company.
 
 
13.                    Stockholders equity
 
(a)           Mr. S. Leslie Flegel was named a director of the Company on March 2, 2007 and on March 1, 2007 was appointed as Chairman and elected as a director of Five Star.  Effective March 2, 2007, Mr. Flegel entered into a three-year agreement with Five Star (the “FS Agreement”) which provides for an annual fee of $100,000 and reimbursement (i) for all travel expenses incurred in connection with his performance of services for Five Star and (ii) beginning in November 2007, for up to $125,000 per year of the cost of maintaining an office. In addition, pursuant to the FS Agreement, Mr. Flegel was issued 2,000,000 shares of Five Star common stock, all of which are fully vested and not subject to forfeiture.  The 2,000,000 shares were valued at $720,000 based on the closing price of Five Star’s common stock on March 2, 2007. Such amount was to be charged to compensation expense over the term of the FS Agreement. At December 31, 2007, the unrecognized compensation was $520,000 of which $240,000 was included in Prepaid expenses and other current assets and $280,000 was included in Other assets. In addition, the Company recognized a gain of $1,000 on the reduction in ownership interest of Five Star at the time of issuance.
 
On March 2, 2007, the Company and Mr. Flegel entered into an agreement pursuant to which the Company sold Mr. Flegel 200,000 shares of the Company’s common stock for $480,000 ($2.40 per share).  The agreement gave Mr. Flegel the right to exchange any or all of the 200,000 shares of the Company’s common stock into shares of Five Star common stock held by the Company at the fixed rate of six shares of Five Star common stock for each share of Company common stock. The value of the option to convert the Company’s stock held by Mr. Flegel into shares of Five Star  which amounted to $264,000, has been valued using a Black Sholes formula and recognized as compensation expense by Five Star over the three year term of the FS Agreement. In addition, as the exchange rights if exercised would require the Company to effectively surrender net assets to redeem common stock, the Company accounted for the issuance of the 200,000 shares as temporary equity at an amount equivalent to the carrying value of Five Star’s equity that could be acquired by the holder of such shares ($493,000 at December 31, 2007).
 
On March 25, 2008, Mr. Flegel resigned as director and Chairman of the Board of Five Star, and as a director of the Company, effective immediately. In connection with Mr. Flegel’s resignation, Five Star, the Company and Mr. Flegel entered into an agreement, dated March 25, 2008, pursuant to which Mr. Flegel sold to the Company (i)  200,000 shares of the Company’s common stock, which was exchangeable into 1,200,000 shares of Five Star common stock owned by the Company, at $3.60 per share, which equates to $0.60 per share of Five Star common stock had Mr. Flegel exercised his right to exchange these shares of the Company’s common stock into shares of Five Star common stock and (ii)  1,698,336, shares of Five Star’s common stock at $0.60 per share.  In addition, Mr. Flegel’s children and grandchildren agreed to sell to the Company an additional 301,664 shares Five Star’s Common Stock at $0.60 per share. The market value of the Company’s common stock on March 25, 2008 was $2.40 per share.  The excess cash paid over the market value of $1.20 per share on the 200,000 shares of Company common stock purchased from Mr. Flegel, or $240,000, was deemed to be the settlement of the option to exchange the Company’s common stock for Five Star stock and was charged to Additional paid in capital. Five Star recorded a compensation charge of $1,096,000 in the first quarter of 2008 (included in Charge related to the resignation of the Chairman of the Board of Five Star) related to the above transactions, including the unrecognized value of the 2,000,000 shares of Five Star common stock issued and the option to convert the 200,000 shares of Company common stock discussed above.  In addition, the expense included $440,000, which represents the excess of the purchase price over the quoted market price of the 2,000,000 shares of Five Star common stock on the date of the agreement to acquire such shares. The Lender amended the covenants related to the Loan Agreement in March 2008 to exclude non-cash charges related to any equity instruments (common stock, options and warrants) issued to any employee, director, or consultant from the covenant calculations (see Note 7 to the Consolidated Condensed Financial Statements).
 
The agreement also contained one-year non-compete, standstill and non-solicitation provisions. In addition, the three year FS Agreement was terminated upon his resignation.
 
(b)           As of December 31, 2007, warrants were outstanding to acquire 1,423,887 shares of the Company’s common stock at $3.57 per share. The warrants expire in August 2008.
 

14.                    Income taxes

As the result of the resignation of S. Leslie Flegel, former director and Chairman of the Board of Five Star (see Note 13(a)) a compensation expense of $1,096,000 was recorded of which $704,000 did not result in a tax benefit. Such amount was treated as a discrete item. The tax effect of the discrete items are reflected in the periods in which they occur and not reflected in the estimated annual effective tax rate which is used for interim period tax provisions. This resulted in no tax benefit being recorded by Five Star for the three months ended March 31, 2008.


Item 2.             Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Cautionary Statement Regarding Forward-Looking Statements
 
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward looking statements. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We use words such as “expects”, “intends”, “believes”, “may”, “will” and “anticipates” to indicate forward-looking statements.
 
Factors that may cause actual results to differ from those results expressed or implied, include, but are not limited to, those listed under “Risk Factors” in our Annual Reports on Form 10-K filed with the Securities and Exchange Commission (the “SEC”); an unexpected decline in revenue and/or net income derived by the Company’s wholly-owned subsidiary, MXL Industries, Inc. (“MXL”), or by our majority-owned subsidiary, Five Star Products, Inc. (“Five Star”), due to the loss of business from significant customers or otherwise. In addition, MXL is dependant on the availability and pricing of plastic resin, principally polycarbonate, and Five Star is subject to the intense competition in the do-it -yourself industry.
 
We caution that these risk factors may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict these new risk factors, nor can we assess the effect, if any, of the new risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ from those expressed or implied by these forward-looking statements.
 
If any one or more of these expectations and assumptions proves incorrect, actual results will likely differ materially from those contemplated by the forward-looking statements. Even if all of the foregoing assumptions and expectations prove correct, actual results may still differ materially from those expressed in the forward-looking statements as a result of factors we may not anticipate or that may be beyond our control. While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the differences could be significant. We do not undertake to update any forward-looking statements made by us, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report.
 
General Overview
 
The Company operates in two segments: MXL and Five Star.  The Company also owns certain other non-core assets, including an investment in a publicly held company, Millennium Cell and certain real estate in Pawling, New York and Killingly, Connecticut.  The Company monitors Millennium Cell for progress in the commercialization of Millennium Cell’s emerging technology and monitors Indevus for progress in achieving certain milestones related to contingent stock rights.  In the year ended December 31, 2007, the Company sold 2,639,482 shares of Indevus stock, which represents all of the shares of Indevus common stock held by the Company in 2007.   The Company may receive two contingent tranches of Indevus common stock, to the extent certain milestones with respect to specific product candidates are achieved. If each of the contingent milestones is achieved, the Company will receive $2,070,670 and $3,106,005, respectively, worth of Indevus common stock on the date the milestone is met, at which date additional gain will be recognized (see Notes 9 and 11(a) to the Consolidated Condensed Financial Statements).
 
MXL Overview
 
The primary business of MXL is the manufacture of polycarbonate parts requiring adherence to strict optical quality specifications, and the application of abrasion and fog resistant coatings to those parts.  MXL also designs and constructs injection molds for a variety of applications.  Some of the products that MXL produces include:
 
 
·
facemasks and shields for recreation purposes and industrial safety companies;
 
 
·
precision optical systems, including medical optics, military eye wear and custom molded and decorated products; and
 
 
·
tools, including optical injection mold tools and standard injection mold tools.
 

MXL manufactures and sells its products to various commercial and government customers, who utilize MXL’s parts to manufacture products that will be ultimately delivered to the end-user.  MXL’s government customers include various offices of the Department of Defense, while MXL’s commercial customers are primarily in the recreation, safety, and security industries. Some of MXL’s consumer based products are considered to be at the high-end of their respective markets.   As a result, sales of MXL’s products may decline together with a decline in discretionary consumer spending; therefore a key performance indicator that the Company’s management uses to manage the business is the level of discretionary spending in key markets, specifically the United States and Japan.
 
MXL believes that the principal strengths of its business are its state-of-the-art injection molding equipment, advanced production technology, high quality standards, and on time deliveries.  However, due to the focused nature of the market, MXL has a limited customer base and tends to be adversely affected by a loss in business from its significant customers.
 
Five Star Overview
 
Five Star is a publicly held company that is a distributor in the United States of home decorating, hardware, and finishing products.  Five Star offers products from leading manufacturers in the home improvement industry and distributes those products to retail dealers, which include lumber yards, “do-it yourself” centers, hardware stores and paint stores.  Five Star has grown to be one of the largest independent distributors in the Northeast United States by providing a complete line of competitively priced products, timely delivery and attractive pricing and financing terms to its customers.
 
Five Star operates in the Home Improvement market.  Five Star faces intense competition from large national distributors, smaller regional distributors, and manufacturers that bypass the distributor and sell directly to the retail outlet.  The principal means of competition for Five Star are its strategically placed distribution centers and its extensive inventory of quality, name-brand products.  In addition, Five Star’s customers face stiff competition from Home Depot and Lowe’s, which purchase directly from manufacturers. Management of Five Star believes that, the independent retailers that are Five Star’s customers remain a viable alternative to Home Depot and Lowe’s, due to the shopping preferences of and the retailer’s geographic convenience for some consumers.
 
On April 5, 2007, Five Star acquired substantially all the assets (except “Excluded Assets” as defined) and assumed the Assumed Liabilities (as defined) of Right-Way Dealer Warehouse, Inc. (“Right-Way”) pursuant to the terms of a definitive asset purchase agreement, dated as of March 13, 2007 (the “Agreement”), with Right-Way for approximately $3,200,000 in cash and the assumption of liabilities in the approximate amount of $50,000. Transaction costs of $200,000 were incurred by Five Star.  The assets consisted primarily of approximately $1,186,000 of accounts receivable at fair value and approximately $2,213,000 of inventory at fair value. The acquisition included all of Right-Way’s Brooklyn Cash & Carry business and operations which sells paint sundry and hardware supplies to local retail stores.
 
Upon closing of the transaction, Five Star leased a warehouse at which the Right-Way Brooklyn Cash & Carry business is conducted from an affiliate of the principal of Right-Way, with an option to purchase the warehouse.  See Note 4 to the Consolidated Condensed Financial Statements.
 
To further expand, Five Star is considering strategies intended to grow its revenue base in the Northeast and Mid-Atlantic States through internal initiatives and to acquire complementary distributors outside its current geographic area.  There is no assurance that these growth plans can be executed and, if executed, will be successful from an operational or financial standpoint.  These plans could require capital in excess of the funds presently available to Five Star.
 

Management discussion of critical accounting policies
 
The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Our estimates, judgments and assumptions are continually evaluated based on available information and experience.  Because of the use of estimates inherent in the financial reporting process, actual results could differ from those estimates.
 
Certain of our accounting policies require higher degrees of judgment than others in their application.  These include valuation of accounts receivable, accounting for investments, and impairment of long-lived assets which are summarized below.
 
Revenue recognition
 
Revenue on product sales is recognized at the point in time when the product has been shipped, title and risk of loss has been transferred to the customer, and the following conditions are met: persuasive evidence of an arrangement exists, the price is fixed and determinable, and collectability of the resulting receivable is reasonably assured.  Allowances for estimated returns and allowances are recognized when sales are recorded.
 
Stock based compensation
 
The Company accounts for stock based compensation pursuant to Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (“SFAS 123R”). Under SFAS 123R, compensation cost is recognized over the vesting period based on the fair value of the award at the grant date.
 
Valuation of accounts receivable
 
Provisions for allowance for doubtful accounts are made based on historical loss experience adjusted for specific credit risks.  Measurement of such losses requires consideration of the Company’s historical loss experience, judgments about customer credit risk, and the need to adjust for current economic conditions.  
 
Impairment of long-lived tangible assets
 
Impairment of long-lived tangible assets with finite lives results in a charge to operations whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of long-lived tangible assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset.  If such assets are considered to be impaired, the impairment to be recognized is measured by determining the amount by which the carrying amount of the assets exceeds the fair value of the asset.  Assets to be disposed of are reported at the lower of their carrying amount or fair value less cost of sale.
 
The measurement of the future net cash flows to be generated is subject to management’s reasonable expectations with respect to the Company’s future operations and future economic conditions which may affect those cash flows.
 
The Company holds the Pawling Property, which is undeveloped land in Pawling, New York with a carrying amount of approximately $2.5, million which management believes is less than its fair value, less cost of sale and property in East Killingly, Connecticut with a carrying amount of approximately $0.4 million.
 
Accounting for investments
 
The Company’s investment in marketable securities are classified as available-for-sale and recorded at their market value with unrealized gains and losses recorded as a separate component of stockholders’ equity.  A decline in market value of any available-for-sale security below cost that is deemed to be other than temporary, results in an impairment loss, which is charged to earnings.
 
Determination of whether an investment is impaired and whether an impairment is other than temporary requires management to evaluate evidence as to whether an investment’s carrying amount is recoverable within a reasonable period of time considering factors which include the length of time that an investment’s market value is below its carrying amount and the ability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment.
 
 
Vendor allowances
 
The Company accounts for vendor allowances under the guidance provided by EITF Issue No. 02-16, “Accounting by a Customer (Including a Reseller) for Certain Consideration Received from a Vendor,” and EITF Issue No. 03-10, “Application of EITF Issue No. 02-16 by Resellers to Sales Incentives Offered to Consumers by Manufacturers.” Vendor allowances reduce the carrying cost of inventory unless they are specifically identified as a reimbursement for promotional programs and/or other services provided. Any such allowances received in excess of the actual cost incurred also reduce the carrying cost of inventory. 
 
Income taxes
 
Income taxes are provided for based on the asset and liability method of accounting pursuant to Statement of Financial Accounting Standards (“SFAS”) No. 109, “Accounting for Income Taxes” and FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109”. Under SFAS No. 109, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Under SFAS No. 109, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Results of Operations
 
Three months ended March 31, 2008 compared to the three months ended March 31, 2007
 
Income (loss) before income taxes and minority interest
 
For the three months ended March 31, 2008, the Company had a loss before income tax expense and minority interests of $1,376,000 compared to income before income tax expense and minority interests of $128,000 for the three months ended March 31, 2007. The decrease in Income (loss) before income taxes and minority interest of $1,504,000 for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007, is primarily a result the following: (i) reduced operating profit at Five Star of $1,489,000 due to (a) a $1,096,000 compensation expense related to the termination of  the Company’s agreement with S. Leslie Flegel and the effect of the purchase by the Company of the 2,000,000 shares of  the Company’s common stock owned by Mr. Flegel (see Note 13 to the Consolidated Condensed Financial Statements), which is reflected in Charge related to  resignation of Chairman of the Board of Five Star in the Consolidated Condensed Statement of Operations, (b) increased general and administrative expenses primarily due the acquisition of Right-Way in April 2007, (c) increased selling expenses due to increased sales, and (d) partially offset by increased gross margin due to increased sales, and (ii)  increased expenses at the corporate level.  This decrease was partially offset by increased operating profit of $298,000 at MXL, due to costs incurred in the first quarter of 2007 related to MXL’s closure of its Illinois facility.
 
Sales
 
 
Three months
ended March 31,
 
 
2008
 
2007
 
Five Star
  $ 31,469,000     $ 29,861,000  
MXL
    2,339,000       2,070,000  
    $ 33,808,000     $ 31,931,000  

The increased Five Star sales of $1,608,000 were due to sales generated by Right-Way Brooklyn (Five Star’s Cash and Carry facility purchased in April 2007), Cabot drop ship sales that occurred in the second quarter of 2007 being shipped in the first quarter of 2008 due to a change in the program by Cabot, offset by reduced sales out of the New Jersey and Connecticut warehouses due to an overall weakness in the marketplace.
 

The increase in MXL sales of $269,000 for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007 was the result of increased sales from MXL’s existing base.
 
Gross margin
 
   
Three months ended
   
March 31,
   
2008
 
 %
 
2007
 
 %
Five Star
 
$
5,176,000
 
16.4
 
$
4,728,000
 
15.8
MXL
   
609,000
 
26.0
   
362,000
 
17.5
   
$
5,785,000
 
15.9
 
$
5,090,000
 
15.9

Five Star’s increased gross margin of $448,000 and increased gross margin percentage is due to the following: (i) increased sales of $1,608,000, and (ii) increased gross margin percentage due to increased vendor allowances earned in the period, which were offset by increased warehouse expenses due to an overall increase in operating costs due to Right-Way and increased prices.
 
MXL’s increased gross margin of $247,000 and increased gross margin percentage for the three months ended March 31, 2008 was due to the following: (i) increased costs of approximately $167,000  for the quarter ended March 31, 2007 at MXL’s  Illinois facility due to the increased costs incurred and reduced revenue generated due to the commencement of closing of the facility during the quarter ended March 31, 2007, (ii) increased sales in 2008 and (iii) improved product mix for the three months ended March 31, 2008.
 
Selling, general, and administrative expenses
 
For the three months ended March 31, 2008, selling, general and administrative expenses increased by $1,123,000 from $4,702,000 for the three months ended March 31, 2007 partially due to the following: (i) an increase in  SG&A of $841,000 at Five Star due to; (a) increased selling expenses of $162,000 as a result of increased commissions due to increases sales and other sales related operating expenses and (b) increased general and administrative expenses of $517,000 due to increased costs incurred due to Right-Way, as well as a general increase in operating costs, (ii) reduced SG&A at MXL of $50,000 due to the closing of MXL’s Illinois facility in 2007, and (iii) increased SG&A at the corporate level primarily due to equity based compensation expense and increased professional fees.
 
Investment and other income (loss), net
 
The Company recognized investment and other income of $100,000 for the three months ended March 31, 2008 compared to income of  $66,000 for the three months ended March 31, 2007.  The change of $34,000 was due to increased interest income due to increased balances of cash and cash equivalents.
 
Income taxes
 
For the three months ended March 31, 2008 and 2007, the Company recorded an income tax expense of $14,000 and $360,000, respectively, which represents the Company’s applicable federal, state and local tax expense for the periods.  The provision for income taxes differs from the tax computed at the federal statutory income tax rate due primarily to recording income tax expense on the income (loss) of Five Star, a 75% owned subsidiary, which is not included in the Company’s consolidated return, and not recording an income tax benefit for the losses of National Patent.  As the result of the resignation of S. Leslie Flegel, former director and Chairman of the Board of Five Star (see Note 13) a  compensation expense of $1,096,000 was recorded by Five Star of which $704,000 did not result in a tax benefit. Such amount was treated as a discrete item. The tax effect of the discrete items are reflected in the periods in which they occur and not reflected in the estimated annual effective tax rate which is used for interim period tax provisions. This resulted in no tax benefit being recorded by Five Star for the three months ended March 31, 2008.

 
Financial condition
 
At March 31, 2008, the Company had $11,505,000 of cash and cash equivalents at the corporate level, which is primarily attributable to the net proceeds realized from the sale of Indevus shares.
 

Liquidity and capital resources
 
At March 31, 2008, the Company had cash and cash equivalents totaling of $12,366,000. The Company believes that cash, investments on hand and borrowing availability under existing credit agreements will be sufficient to fund the Company’s working capital requirements for at least the next twelve months.
 
For the three months ended March 31, 2008, the Company’s working capital decreased by $3,329,000 to $20,925,000 from $24,254,000 as of December 31, 2007.
 
The decrease in cash and cash equivalents of $3,332,000 for the three months ended March 31, 2008 resulted from net cash used in operations of $8,782,000, due primarily to a net loss of $1,377,000, an increase in accounts receivable of $7,995,000, an increase in inventory of $6,086,000, partially offset by an increase in accounts payable and accrued expenses of $5,384,000; net cash used in investing activities of $1,690,000, primarily consisting of purchases of Five Star common stock for $1,523,000, which was comprised of $763,000 in open market purchases and $1,200,000 from S. Leslie Flegel, the former Chairman of Five Star, of which $440,000 was charged to operations (see Note 13 to the Consolidated Condensed Financial Statements); and net cash provided by financing activities of $7,140,000, consisting of proceeds of short term borrowings of $8,173,000,  offset by purchases of treasury stock of $729,000. The significant changes in accounts receivables, inventory and accounts payable is primarily due to the particulars of Five Star’s business in the first quarter, including their trade show, spring dating programs and increased inventory levels for the spring.
 
 In 2003, Five Star obtained a Loan and Security Agreement (the “Loan Agreement”) with Bank of America Business Capital (formerly Fleet Capital Corporation) (the “Lender”). The Loan Agreement has a five-year term, with a maturity date of June 30, 2008. The Loan Agreement, as amended in August 1, 2005 provides for a $35,000,000 revolving credit facility, which allows Five Star to borrow based upon a formula of up to 65% of eligible inventory and 85% of eligible accounts receivable, as defined therein. The interest rates under the Loan Agreement consist of LIBOR plus a credit spread of 1.5% (4.57% at March 31, 2008) for borrowings not to exceed $15,000,000 and the prime rate (5.25% at March 31, 2008) for borrowings in excess of the above-mentioned LIBOR-based borrowings. The credit spreads can be reduced in the event that Five Star achieves and maintains certain performance benchmarks. At March 31, 2008 and December 31, 2007, approximately $27,476,000 and $19,303,000 was outstanding under the Loan Agreement and approximately $7,390,000 and $5,579,000 was available to be borrowed, respectively. Substantially all of Five Star’s assets are pledged as collateral for these borrowings.
 
Under the Loan Agreement Five Star is subject to covenants requiring minimum net worth, limitations on losses, if any, and minimum or maximum values for certain financial ratios. As of March 31, 2008 Five Star was in compliance with all required covenants. The following table sets forth the significant debt covenants at March 31, 2008:
 
Covenant
 
Required
 
Calculated
Minimum tangible net worth
 
$6,000,000
 
$9,512,000
Debt to tangible net worth
 
< 6
 
2.89
Fixed charge coverage
 
>1.1
 
1.78
Quarterly income, as adjusted
 
No loss in consecutive quarters
 
$489,000 – first quarter profit (*)

 
*
The Lender amended the covenants related to the Loan Agreement in March 2008 to exclude non-cash charges related to any equity instruments (common stock, options and warrants) issued to any employee, director, or consultant from the covenant calculations (see Note 7 to the Consolidated  Condensed Financial Statements).
 
On March 1, 2005, MXL obtained a Line of Credit Loan (the “MXL Line”) from M&T Bank with a one year term, maturing on March 1, 2006, which has been extended to June 30, 2006 on the same terms. The MXL Line provides for a $1,000,000 revolving credit facility, which is secured by MXL’s eligible accounts receivable, inventory and a secondary claim on the Lancaster, PA property.  On November 27, 2006 the MXL Line was amended to a $900,000 line of credit.  The interest rates under the MXL Line consist of LIBOR plus a credit spread of 3% or the prime rate plus a credit spread of 0.25%. The MXL Line is subject to an unused commitment fee of 0.25% of the average daily unused balance of the line payable quarterly. The Company has guaranteed the MXL Line. At March 31, 2008, $625,000 was outstanding under the MXL Line and $ 275,000 was available to be borrowed. The MXL Line contains certain financial covenants, most significant being a cash flow coverage ratio (as defined) of 1.25 to 1.00, which is calculated at December 31.  At December 31, 2007, MXL was in compliance with its covenants.
 
 
Contractual Obligations and Commitments
 
GP Strategies has guaranteed the leases for Five Star’s New Jersey and Connecticut warehouses, totaling approximately $1,600,000 per year through the first quarter of 2009. GP Strategies’ guarantee of such leases was in effect when Five Star was a wholly-owned subsidiary of GP Strategies. As part of the spin-off, the landlord of the New Jersey and Connecticut facilities and the lessor of the equipment did not consent to the release of GP Strategies’ guarantee.  In February 2008, Five Star extended the lease for the New Jersey warehouse for 12 months to March 31, 2010.  In addition, the lease for the New Jersey warehouse will no longer be guaranteed by GP Strategies, but will be guaranteed by the Company.
 
Recent accounting pronouncements
 
In March 2008, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 161 (“SFAS No. 161”), “Disclosures about Derivative Instruments and Hedging Activities - an amendment of FASB Statement No. 133”. SFAS No. 161 gives financial statement users better information about the reporting entity's hedges by providing for qualitative disclosures about the objectives and strategies for using derivatives, quantitative data about the fair value of and gains and losses on derivative contracts, and details of credit-risk-related contingent features in their hedged positions. The standard is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application encouraged, but not required. The Company does not anticipate that the adoption of SFAS No. 161 will have a material effect on the Company’s consolidated financial statements.
 
In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”, which defines fair value, establishes a framework for measurement fair value and expands disclosures about fair value measurements. SFAS No. 157 clarifies that fair value should be based on assumptions that market participants will sue when pricing an assets or liability and establishes a fair value hierarchy of three levels that  prioritize the information used to develop those assumptions. The provisions of SFAS No. 157 will become effective for the Company beginning January 1, 2008. Generally, the provisions of this statement are to be applied prospectively. The Company adopted SFAS No. 157 in the first quarter of 2008. The adoption of SFAS No. 157 did not have a material effect on the Company’s consolidated financial statements.
 
In February, 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities”.  This statement provides companies with an option to report selected financial assets and liabilities at fair value. This statement is effective for fiscal years beginning after November 15, 2007 with early adoption permitted. SFAS No. 159 did not have any material effect on the Company’s consolidated financial statements. 
 
In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements — an amendment of Accounting Research Bulletin (“ARB”) No. 51” (“SFAS 160”).  SFAS 160 requires that ownership interests in subsidiaries held by parties other than the parent, and the amount of consolidated net income, be clearly identified, labeled, and presented in the consolidated financial statements within equity, but separate from the parent’s equity. It also requires once a subsidiary is deconsolidated, any retained noncontrolling equity investment in the former subsidiary be initially measured at fair value. Sufficient disclosures are required to clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners.  SFAS No. 160 is effective for fiscal years beginning after December 15, 2008, and is not expected to have a significant impact on the Company’s results of operations, financial condition and liquidity.
 
In December 2007, the FASB issued SFAS No. 141 (Revised 2007), “Business Combinations”. SFAS No. 141(R), replaces SFAS No. 141, “Business Combinations”, and establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree, and any goodwill acquired in a business combination. SFAS No. 141(R) also establishes disclosure requirements to enable the evaluation of the nature and financial effects of a business combination. SFAS No. 141(R) is to be applied prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008.  We have not yet determined the impact that the adoption of SFAS No. 141(R) will have on its result of operations or financial position.
 

Item 3.             Quantitative and Qualitative Disclosure About Market Risk
 
Not required.
 
Item 4.             Controls and Procedures
 
The Company’s principal executive officer and principal financial officer, with the assistance of other members of the Company’s management, have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based upon such evaluation, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report.
 
The Company’s principal executive officer and principal financial officer have also concluded that there was no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2008 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
PART II. OTHER INFORMATION
 
Item 2.             Unregistered Sales Of Equity Securities and Use of Proceeds.
 
The following table provides common stock repurchases made by or on behalf of the Company during the first quarter ended March 31, 2008.

Issuer Purchases of Equity Securities (1)(2)
 
Period
 
Total
Number of
Shares
Purchased
   
Average
Price Paid
Per Share
   
Total Number of
Shares Purchased
As Part of
Publicly
Announced Plan
or Program
   
Maximum
Number of
Shares That
May Yet be
Purchased
Under the Plan
or Program
 
Beginning
Ending
                       
January 1, 2008
January 31, 2008
                       
February 1, 2008
February 29, 2008
    100,000     $ 2.45       100,000       371,538  
March 1, 2008
March 31, 2008
    200,000     $ 3.60               371,538  
                                   
 
Total
    300,000               100,000          

 
(1)
On December 15, 2006, the Company’s Board of Directors authorized the Company to repurchase up to 2,000,000 shares, or approximately 11%, of its outstanding shares of common stock on that date, from time to time either in open market or privately negotiated transactions. The Company undertook this repurchase program in an effort to increase shareholder value.  

 
(2)
In connection with the resignation by Mr. Flegel as director of the Company, and as director and Chairman of the Board of Five Star, effective March 25, 2008, the Company, Five Star and Mr. Flegel entered into an agreement, dated March 25, 2008, pursuant to which, among other things, Mr. Flegel sold to the Company 200,000 shares of Company common stock, which was exchangeable into 1,200,000 shares of Five Star common stock owned by the Company, at $3.60 per share (which equates to $0.60 per share of Five Star common stock had Mr. Flegel exercised his right to exchange these shares of Company common stock into shares of Five Star common stock).

 
Item 6.             Exhibits

Exhibit No.
 
Description
10.1
 
Agreement and Release, dated March 25, 2008, by and among Leslie Flegel, National Patent Development Corporation and Five Star Products, Inc. (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by Five Star Products, Inc. with the Securities and Exchange Commission on March 27, 2008)
     
10.2
 
Sale Agreement, dated March 25, 2008, by and among National Patent Development Corporation, Five Star Products, Inc., Jason Flegel, Carole Flegel, Dylan Zachary Flegel UTMA – FL, Brooke Flegel UTMA – FL, Mark Flegel, Darryl Sagel, Lauren Sagel, Graham Spencer Sagel UTMA – NY and Alexa Danielle Sagel UTMA – NY (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K filed by Five Star Products, Inc. with the Securities and Exchange Commission on March 27, 2008)
     
31.1
*
Certification of principal executive officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
     
31.2
*
Certification of principal financial officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
     
32.1
*
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the principal executive officer of the Company and the principal financial officer of the Company
     
   
*Filed herewith
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed in its behalf by the undersigned thereunto duly authorized.
 
     
   
NATIONAL PATENT DEVELOPMENT CORPORATION
     
     
Date: May 15, 2008
 
/s/ HARVEY P. EISEN
   
Name: Harvey P.Eisen
   
Title: Chairman of the Board and Chief Executive Officer
     
     
     
Date: May 15, 2008
 
/s/ IRA J. SOBOTKO
   
Name: Ira J. Sobotko
   
Title: Vice President, Finance
 

26